Literature DB >> 10637467

Testosterone supplementation in the aging male.

Y C Kim1.   

Abstract

World-wide life expectancy at birth for men and women will have increased by about 20 y during 50 y period between 1950 and 2000. As a result, the proportion of the elderly population is expected to increase significantly in the 21st century. Despite this increase in longevity for men and women, men still have significantly shorter life expectancy of approximately 5 y. To further reduce and prevent debilitating disease and disability in elderly men, a question is whether any type of interventions, such as hormone replacement therapy, may play a role in improving the quality of life as proven in post-menopausal women. Men experience age-related decline of capability physically and mentally. Various symptoms, such as nervousness, depression, impaired memory, inability to concentrate, easy fatigability, insomnia, hot flushes, periodic sweating, reduction of muscle mass and power, bone ache, and sexual dysfunction, are related to this change. The fact that a number of age-related changes resemble features of various hormonal deficiency has led to worldwide interest in the use of various hormonal preparations in an effort to prevent the aging process in elderly men. Even though there have been opinions against hormonal supplementation in the aging male, preliminary studies defining the risk/benefit ratio of androgen supplementation appear to be encouraging. To understand testosterone supplementation in the aging male, this review will discuss the following important topics: physiology of male hormonal balance, changes in reproductive organs in elderly men, endocrine evaluation of the male, pharmacological effects of testosterone on target organs, available preparations for testosterone, and testosterone supplementation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10637467     DOI: 10.1038/sj.ijir.3900446

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  8 in total

Review 1.  Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression.

Authors:  L Zakaria; A G Anastasiadis; R Shabsigh
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Diagnostic index and dysfunction treatment.

Authors:  J Rajfer
Journal:  Rev Urol       Date:  2000

Review 3.  Impact of androgen deprivation therapy on sexual function.

Authors:  Clarisse R Mazzola; John P Mulhall
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

4.  Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.

Authors:  Prasanth N Surampudi; Christina Wang; Ronald Swerdloff
Journal:  Int J Endocrinol       Date:  2012-03-14       Impact factor: 3.257

5.  Short-Term Exercise Training Inconsistently Influences Basal Testosterone in Older Men: A Systematic Review and Meta-Analysis.

Authors:  Lawrence D Hayes; Bradley T Elliott
Journal:  Front Physiol       Date:  2019-01-14       Impact factor: 4.566

6.  Effects of Exercise Training on Anabolic and Catabolic Hormones with Advanced Age: A Systematic Review.

Authors:  Abderraouf Ben Abderrahman; Anthony C Hackney; Hassane Zouhal; Ayyappan Jayavel; Kamalanathan Parasuraman; Lawrence D Hayes; Claire Tourny; Fatma Rhibi; Ismail Laher
Journal:  Sports Med       Date:  2021-12-22       Impact factor: 11.928

7.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

8.  Risk of erectile dysfunction induced by arsenic exposure through well water consumption in Taiwan.

Authors:  Fang-I Hsieh; Ti-Sheng Hwang; Yi-Chen Hsieh; Hsiu-Chiung Lo; Chien-Tien Su; Hui-Shing Hsu; Hung-Yi Chiou; Chien-Jen Chen
Journal:  Environ Health Perspect       Date:  2008-04       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.